Stereotactic ablative radiotherapy for oligometastatic disease in liver.

about

Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient.

P2860

Q55524986-11F8E19D-1FA4-490B-9F09-4C52CE1E6A88

P2860

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

Item

http://www.wikidata.org/entity/Q39598540

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

@en

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

@nl

type

Item

label

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

@en

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

@nl

prefLabel

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

@en

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

@nl

P1476

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

@en

P2093

Chul Seung Kay

http://www.w3.org/2001/XMLSchema#string

Myungsoo Kim

http://www.w3.org/2001/XMLSchema#string

Seok Hyun Son

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors

Review and uses of stereotactic body radiation therapy for oligometastases

Cancer statistics, 2012

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.

Stereotactic body radiation therapy for colorectal liver metastases.

Stereotactic body radiotherapy for oligometastases.

Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

P304

340478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1155/2014/340478

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Yong Kyun Won

P5008

ScienceSource

P577

2014-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262680382

http://www.w3.org/2001/XMLSchema#string

P698

24868526

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

4020541

http://www.w3.org/2001/XMLSchema#string

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

about

P2860

P2860

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P50

P5008

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P50

P5008

P577

P5875

P698

P921

P932